logo
Prescription drug overdoses driving death toll

Prescription drug overdoses driving death toll

Isabella Higgins: In just one year, more than 2,000 Australians died of a drug overdose. Most were unintentional deaths. That's the stark headline figure of new analysis being released this week looking into drug-induced deaths. And advocates say illegal drugs aren't the only problem. Here's National Health Equity reporter, Caitlyn Gribbin.
Caitlyn Gribbin: There's a stereotype about drug-related deaths that John Ryan wants to put a stop to.
John Ryan : That idea that it's only illegal drugs is wrong. The overdose toll is actually made up of some people that inject drugs, definitely, but much of the overdose toll is people that are using pharmaceutical drugs, prescription drugs.
Caitlyn Gribbin: John Ryan's the chief executive of the Penington Institute, a not-for-profit drug research group. It's released new research revealing 189 fatal overdoses every four weeks. Proof, Mr Ryan insists, that a new approach is needed to deal with dangerous drug use.
John Ryan : We're losing the equivalent of a Boeing 737 full of Australians every month. The overdose toll has long exceeded the road toll.
Caitlyn Gribbin: Early analysis of the report breaks down the most recent Australian Bureau of Statistics data on drug-induced deaths, which is from 2023. Overdose deaths were down 6% on the previous year, but John Ryan says figures will increase when ABS data revisions come in. The numbers are confronting, with nearly 2,300 people dying of a drug overdose. More than three-quarters were unintentional deaths. Opioids such as heroin and pharmaceutical opioids remain the most common drug type involved in unintentional deaths, contributing to almost half. But the proportion of drug-related fatalities involving stimulants such as methamphetamine and also cocaine increased on previous years.
Amanda Roxburgh : Australia is a major destination for methamphetamine. We've got high numbers of large seizures being detected at our borders.
Caitlyn Gribbin: Amanda Roxburgh, a senior research fellow and clinical psychologist at medical research organisation the Burnet Institute, says the highly potent crystal methamphetamine is the predominant stimulant drug now being used in Australia.
Amanda Roxburgh : We're not only seeing increases in deaths related to methamphetamine, but we're also seeing increases in methamphetamine-related hospitalisations. So it's relatively cheap to buy and it's really readily available.
Caitlyn Gribbin: The Penington analysis also found drug-induced deaths involving stimulants overtook benzodiazepines like Valium as the second most common drug type involved in fatal overdoses. Most drug overdoses are polysubstance overdoses. They involve more than one drug. John Ryan says pharmaceutical opioids such as codeine and oxycodone and those from the benzodiazepine family such as diazepam or Valium are commonly involved in overdose deaths.
John Ryan : The daughter of a friend of mine who went through a messy divorce ended up on benzodiazepines to manage the stress and anxiety and one night drank a bit more red wine than normal, fell asleep on the couch and was found dead the next day. An absolutely tragic example of a middle-aged woman with two young children who died from a combination of prescribed pharmaceuticals and alcohol. Most of these deaths are occurring in private homes and often it's lounge rooms in suburbia and regional and rural towns.
Caitlyn Gribbin: Mr Ryan says only a small amount of funding goes to harm reduction such as overdose education, the opioid overdose reversal drug naloxone, drug testing and safe injecting facilities. A much bigger share goes to law enforcement. The full overdose report will be out this year.
Isabella Higgins: Caitlin Gribbin reporting. In a statement the Federal Department of Health says the National Drug Strategy provides a commitment to harm minimisation through a balanced adoption of evidence-based demand, supply and harm reduction strategies.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Having kids shouldn't be a luxury. It's time we cut the cost of IVF
Having kids shouldn't be a luxury. It's time we cut the cost of IVF

Sydney Morning Herald

time21 minutes ago

  • Sydney Morning Herald

Having kids shouldn't be a luxury. It's time we cut the cost of IVF

For most major milestones in life, the financial path towards achieving them is relatively straightforward. Whether it's buying your first car, taking a life-changing holiday, getting married or buying a home, the way to achieve it always the same: you set a budget and work towards it, slowly but surely seeing your savings grow until you have enough to pull the trigger. But a story published in this masthead this week really drove home that for a growing number of Australians, there's one area of our lives where the path isn't always linear, especially financially, and that's the journey to parenthood. News that a 32-year-old Melbourne man fathered 27 children by 15 different women via informal sperm donation was shocking, but illuminating. It revealed the growing number of people forgoing formal fertility routes such as IVF and choosing riskier options, in large part due to financial constraints. According to the Australian and New Zealand Assisted Reproduction Database, about 20,000 babies are born via IVF each year, while egg freezing has increased by as much as 1567 per cent in Australia over the past decade. In other words, this is a booming industry with no signs of slowing down. That in itself isn't inherently a bad thing. But we need to be realistic about the fact that it's a profit-driven industry worth over $6 billion, the process of IVF is prohibitively expensive, and people find themselves there when they are at their most vulnerable. Loading Depending on where you live and the specialist you see, the average IVF cycle costs between $9000 and $15,000. You might get some of this back via Medicare rebates, but the out-of-pocket costs are substantial. While some states like Victoria have begun rolling out IVF services via public healthcare, the wait times to see specialists are as long as two years. And as anyone who has had children, is thinking about one day having them, or is currently trying, knows: time is the cruel enemy of fertility. Hence, why most people will invariably end up in the private system. For context, a healthy woman with no pre-existing conditions in her 20s has a 25 to 30 per cent chance of falling pregnant naturally, but this starts to decline throughout her late 20s and early 30s. Once she reaches 35, this decline becomes swift, and by the time she's 40, the chance of falling pregnant naturally is roughly 5 per cent.

Having kids shouldn't be a luxury. It's time we cut the cost of IVF
Having kids shouldn't be a luxury. It's time we cut the cost of IVF

The Age

time21 minutes ago

  • The Age

Having kids shouldn't be a luxury. It's time we cut the cost of IVF

For most major milestones in life, the financial path towards achieving them is relatively straightforward. Whether it's buying your first car, taking a life-changing holiday, getting married or buying a home, the way to achieve it always the same: you set a budget and work towards it, slowly but surely seeing your savings grow until you have enough to pull the trigger. But a story published in this masthead this week really drove home that for a growing number of Australians, there's one area of our lives where the path isn't always linear, especially financially, and that's the journey to parenthood. News that a 32-year-old Melbourne man fathered 27 children by 15 different women via informal sperm donation was shocking, but illuminating. It revealed the growing number of people forgoing formal fertility routes such as IVF and choosing riskier options, in large part due to financial constraints. According to the Australian and New Zealand Assisted Reproduction Database, about 20,000 babies are born via IVF each year, while egg freezing has increased by as much as 1567 per cent in Australia over the past decade. In other words, this is a booming industry with no signs of slowing down. That in itself isn't inherently a bad thing. But we need to be realistic about the fact that it's a profit-driven industry worth over $6 billion, the process of IVF is prohibitively expensive, and people find themselves there when they are at their most vulnerable. Loading Depending on where you live and the specialist you see, the average IVF cycle costs between $9000 and $15,000. You might get some of this back via Medicare rebates, but the out-of-pocket costs are substantial. While some states like Victoria have begun rolling out IVF services via public healthcare, the wait times to see specialists are as long as two years. And as anyone who has had children, is thinking about one day having them, or is currently trying, knows: time is the cruel enemy of fertility. Hence, why most people will invariably end up in the private system. For context, a healthy woman with no pre-existing conditions in her 20s has a 25 to 30 per cent chance of falling pregnant naturally, but this starts to decline throughout her late 20s and early 30s. Once she reaches 35, this decline becomes swift, and by the time she's 40, the chance of falling pregnant naturally is roughly 5 per cent.

Spike in adverse event reports for ADHD medication Vyvanse
Spike in adverse event reports for ADHD medication Vyvanse

The Australian

time10 hours ago

  • The Australian

Spike in adverse event reports for ADHD medication Vyvanse

Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' The TGA issued an alert about a typo on the Vyvanse label earlier this year. Picture: TGA 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Last year, 1.8m Vyvanse prescriptions were written in Australia, excluding Department of Veterans' Affairs patients, over-the-counter drugs, private prescriptions and public inpatient prescriptions. Picture: NewsWire / Martin Ollman Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said. Blair Jackson Reporter Blair's journalism career has taken him from Perth, to New Zealand, Queensland and now Melbourne. Blair Jackson

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store